Truist Securities analyst Joon Lee lowered the price target on Viking Therapeutic (NASDAQ: VKTX) to $95.00 (from $120.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Citi Starts Viking Therapeutic (VKTX) at NeutralFebruary 7, 2025 6:52 AM Viking Therapeutic (VKTX) PT Lowered to $71 at Piper SandlerFebruary 6, 2025 7:06 AM H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)February 6, 2025 6:41 AM Viking Therapeutics (VKTX) Misses Q4 EPS by 4cFebruary 5, 2025 4:13 PM Form 8-K Viking Therapeutics, For: Feb 05February 5, 2025 4:08 PM Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate UpdateFebruary 5, 2025 4:05 PM Viking Therapeutics (VKTX) call put ratio 16 calls to 1 put with a focus on February 7 weekly calls into quarter resultsFebruary 5, 2025 10:46 AM Form SCHEDULE 13G Viking Therapeutics, Filed by: BlackRock, Inc.February 4, 2025 3:46 PM Viking Therapeutics (VKTX) ticks higher on industry chatterFebruary 4, 2025 10:21 AM